Division of Neuro-Oncology

Drug modifies epigenome in aggressive brain tumors: study

A folic acid-like drug changed a DNA process within brain tumors of glioblastoma patients, according to results from a phase 1 clinical trial.

New Clinician Spotlight: Ryan Merrell

Neuro-oncologist Ryan Merrell, MD, has joined Vanderbilt University Medical Center as chief of the Division of Neuro-Oncology in the Department of Neurology.